← All companies

BSEM

BioStem Technologies, Inc.

BSEM OTC Biological Products, (No Diagnostic Substances) EDGAR ↗

$3.26

+0.14 +4.42%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$3.01 – $11.54

Recent SEC filings

15 most recent

Other filings

10-12B/A AMENDMENT NO. 2 FORM 10-12B Aug 4, 2026 S-1 REGISTRATION STATEMENT Jul 29, 2026 10-12B/A AMENDMENT NO. TO 1 FORM 10-12B Jul 24, 2026 10-12G GENERAL FORM FOR REGISTRATION OF SECURITIES Jul 10, 2026 D Item 06b Jun 3, 2026 DRS/A May 28, 2026 DRS Apr 20, 2026 RW Oct 28, 2025 10-12B/A Jan 23, 2025 10-12B/A Nov 27, 2024 10-12B Sep 27, 2024 D Item 06c Apr 4, 2023 D Item 06b May 25, 2021 D Item 06c Aug 16, 2016 D Item 06b Feb 1, 2016